These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25034107)

  • 1. Inhibitors of the Ras superfamily of small G-proteins. Preface.
    Tamanoi F; Der CJ
    Enzymes; 2013; 34 Pt. B():ix. PubMed ID: 25034107
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical biology of lipidated proteins.
    Triola G; Waldmann H; Hedberg C
    ACS Chem Biol; 2012 Jan; 7(1):87-99. PubMed ID: 22148864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sugar-based inhibitors of Ras activation: biological activity and identification of Ras-inhibitor binding interface.
    Di Domizio A; Peri F
    Enzymes; 2013; 33 Pt A():95-116. PubMed ID: 25033802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State 1(T) inhibitors of activated Ras.
    Kalbitzer HR; Spoerner M
    Enzymes; 2013; 33 Pt A():69-94. PubMed ID: 25033801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of small-molecule Ras inhibitors that display antitumor activity by interfering with Ras·GTP-effector interaction.
    Shima F; Yoshikawa Y; Matsumoto S; Kataoka T
    Enzymes; 2013; 34 Pt. B():1-23. PubMed ID: 25034098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RAS: target for cancer therapy.
    Saxena N; Lahiri SS; Hambarde S; Tripathi RP
    Cancer Invest; 2008 Nov; 26(9):948-55. PubMed ID: 18798058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A two-hybrid approach to identify inhibitors of the RAS-RAF interaction.
    Khazak V; Eyrisch S; Kato J; Tamanoi F; Golemis EA
    Enzymes; 2013; 33 Pt A():213-48. PubMed ID: 25033807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using inhibitors of prenylation to block localization and transforming activity.
    Berzat AC; Brady DC; Fiordalisi JJ; Cox AD
    Methods Enzymol; 2006; 407():575-97. PubMed ID: 16757354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ras inhibition via direct Ras binding--is there a path forward?
    Wang W; Fang G; Rudolph J
    Bioorg Med Chem Lett; 2012 Sep; 22(18):5766-76. PubMed ID: 22902659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting RAS and PI3K in lung cancer.
    Downward J
    Nat Med; 2008 Dec; 14(12):1315-6. PubMed ID: 19057554
    [No Abstract]   [Full Text] [Related]  

  • 11. Boron-based inhibitors of acyl protein thioesterases 1 and 2.
    Zimmermann TJ; Bürger M; Tashiro E; Kondoh Y; Martinez NE; Görmer K; Rosin-Steiner S; Shimizu T; Ozaki S; Mikoshiba K; Watanabe N; Hall D; Vetter IR; Osada H; Hedberg C; Waldmann H
    Chembiochem; 2013 Jan; 14(1):115-22. PubMed ID: 23239555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Farnesyltransferase inhibitors reverse Ras-mediated inhibition of Fas gene expression.
    Zhang B; Prendergast GC; Fenton RG
    Cancer Res; 2002 Jan; 62(2):450-8. PubMed ID: 11809695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An orthosteric inhibitor of the RAS-SOS interaction.
    Nickerson S; Joy ST; Arora PS; Bar-Sagi D
    Enzymes; 2013; 34 Pt. B():25-39. PubMed ID: 25034099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flagellin and lipopolysaccharide stimulate the MEK-ERK signaling pathway in chicken heterophils through differential activation of the small GTPases, Ras and Rap1.
    Kogut MH; Genovese KJ; He H
    Mol Immunol; 2007 Mar; 44(7):1729-36. PubMed ID: 17045653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tailoring Ras-pathway--inhibitor combinations for cancer therapy.
    Blum R; Kloog Y
    Drug Resist Updat; 2005 Dec; 8(6):369-80. PubMed ID: 16356760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Ras superfamily G-proteins.
    Tetlow AL; Tamanoi F
    Enzymes; 2013; 33 Pt A():1-14. PubMed ID: 25033798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clavaric acid and steroidal analogues as Ras- and FPP-directed inhibitors of human farnesyl-protein transferase.
    Lingham RB; Silverman KC; Jayasuriya H; Kim BM; Amo SE; Wilson FR; Rew DJ; Schaber MD; Bergstrom JD; Koblan KS; Graham SL; Kohl NE; Gibbs JB; Singh SB
    J Med Chem; 1998 Nov; 41(23):4492-501. PubMed ID: 9804689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of ras by farnesylthiosalicylate significantly reduces the levels of autoantibodies in two animal models of the antiphospholipid syndrome.
    Katzav A; Kloog Y; Korczyn AD; Molina V; Blank M; Shoenfeld Y; Chapman J
    Immunobiology; 2003; 207(1):47-50. PubMed ID: 12638903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat.
    Pando R; Barshack I; Raz A; Luboshits G; Haklai R; Maysel-Auslender S; Kloog Y; Keren G; George J
    Cardiovasc Pathol; 2010; 19(2):94-101. PubMed ID: 19144546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Yeast screens for inhibitors of Ras-Raf interaction and characterization of MCP inhibitors of Ras-Raf interaction.
    Khazak V; Kato-Stankiewicz J; Tamanoi F; Golemis EA
    Methods Enzymol; 2006; 407():612-29. PubMed ID: 16757356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.